09 Dec 2008 SARS Vaccine Achieves Neutralizing Responses in First U.S. Human Trial
09 Dec 2008 Cytos Biotechnology starts phase IIb clinical study with CYT003-QbG10 monotherapy for the treatment of allergic diseases
03 Dec 2008 Geron Announces Initiation of Phase I Clinical Trial of Vaccine Candidate Targeting Telomerase by MERCK & Co., Inc.
03 Dec 2008 AVI BioPharma Files IND for Clinical Trial of Marburg Virus Treatment
03 Dec 2008 Wyeth Submits European Marketing Authorization Application for its 13-Valent Vaccine for the Prevention of Pneumococcal Disease in Infants and Young Children
03 Dec 2008 Cell Genesys and Takeda Announce Termination of Collaboration Agreement for GVAX Immunotherapy for Prostate Cancer
02 Dec 2008 First-Ever Human Trial of DNA-Based Immunotherapy Delivered Using Inovio Biomedical's Electroporation Technology Shows Safety and Durable Systemic Clinical Response
02 Dec 2008 Protalix BioTherapeutics Announces Completion of Enrollment for its Pivotal Phase III Clinical Trial of Gaucher Disease
01 Dec 2008 GeoVax’s Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America
01 Dec 2008 Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
20 Nov 2008 IDRI and Immune Design Corp. Enter License Agreement on GLA Vaccine Adjuvant
14 Nov 2008 New Data Points to Long Lasting Beneficial Effects of CEL-SCI's Rheumatoid Arthritis Vaccine
13 Nov 2008 GARDASIL(R), Merck's Cervical Cancer Vaccine, Demonstrated Efficacy in Preventing HPV-Related Disease in Males in Phase III Study
12 Nov 2008 Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
05 Nov 2008 Bavarian Nordic reports successful safety data from Phase II study with IMVAMUNE (R)
04 Nov 2008 MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine
03 Nov 2008 Canopus BioPharma Announces Positive Results in Human Study of Novel Peptide Cancer Vaccine
03 Nov 2008 NasVax Commences a Phase I/ IIa Dose-Optimization Clinical Study of VaxiSomeTM-Adjuvanted Influenza Vaccine
31 Oct 2008 Celldex Presents Results from Phase 1 Studies of CDX-1307 with GM-CSF
29 Oct 2008 Nabi Biopharmaceuticals Announces Successful Final Results of NicVAX(r) Immunogenicity Study
29 Oct 2008 Launch of a ph.III clinical trial in adults for Oralair Grasses in the US
27 Oct 2008 High-Dose Influenza Vaccine Shows Increased Immune Response Among Adults 65 Years of Age and Older
27 Oct 2008 Phase 3 Data Indicate Investigational 13-valent Vaccine May Broaden Protection Against Pneumoccocal Disease in Children Younger than Two
27 Oct 2008 Nanoemulsion-Based Intranasal Influenza Vaccine Adjuvant Triggers Robust Immunity Using Significantly Less Antigen
24 Oct 2008 Vaxart Demonstrates Efficacy of Oral Avian Flu Vaccine in Preclinical Studies

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up